LEADER 01939nam  2200529Ia 450 
001 9910451489403321
005 20200520144314.0
035   $a(CKB)1000000000450536
035   $a(OCoLC)58596199
035   $a(CaPaEBR)ebrary10071987
035   $a(SSID)ssj0000096384
035   $a(PQKBManifestationID)11122291
035   $a(PQKBTitleCode)TC0000096384
035   $a(PQKBWorkID)10076849
035   $a(PQKB)11496788
035   $a(MiAaPQ)EBC3377668
035   $a(Au-PeEL)EBL3377668
035   $a(CaPaEBR)ebr10071987
035   $a(OCoLC)883573254
035   $a(EXLCZ)991000000000450536
100   $a20050324d2003      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAccelerating the research, development, and acquisition of medical countermeasures against biological warfare agents$b[electronic resource] $einterim report /$fCommittee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents
210   $aWashington, D.C. $cNational Academies Press$dc2003
215   $a1 online resource (18 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-58259-8 
320   $aIncludes bibliographical references.
606   $aBiological weapons$xHealth aspects
606   $aToxicology
608   $aElectronic books.
615  0$aBiological weapons$xHealth aspects.
615  0$aToxicology.
676   $a615.9
712 02$aInstitute of Medicine (U.S.).$bMedical Follow-up Agency.
712 02$aInstitute of Medicine (U.S.).$bBoard on Life Sciences.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910451489403321
996   $aAccelerating the research, development, and acquisition of medical countermeasures against biological warfare agents$92036561
997   $aUNINA